Mission Produce (AVO)
(Delayed Data from NSDQ)
$12.08 USD
+0.15 (1.26%)
Updated May 9, 2024 04:00 PM ET
After-Market: $12.07 -0.01 (-0.08%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth B Momentum A VGM
Price, Consensus and EPS Surprise
AVO 12.08 +0.15(1.26%)
Will AVO be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for AVO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AVO
Limoneira (LMNR) Reports Q1 Loss, Tops Revenue Estimates
Mission Produce, Inc. (AVO) Misses Q3 Earnings Estimates
AVO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Limoneira (LMNR) Q3 Earnings Lag Estimates
Analysts Estimate Mission Produce, Inc. (AVO) to Report a Decline in Earnings: What to Look Out for
Dole (DOLE) Q2 Earnings and Revenues Surpass Estimates
Other News for AVO
IN BRIEF: Advanced Oncotherapy financing talks continue, funds delayed
Advanced Oncotherapy’s Critical Financing Update
3 Vegan Stocks to Buy Now: Q2 Edition
Vital Farms: Further Upside Is On The Table
Mission Produce Executives to Attend Annual Roth Conference